Results 291 to 300 of about 216,439 (378)
Research on the functions and potential mechanisms of STAT3 in chronic myelogenous leukemia. [PDF]
Feng X, Qin Y, Feng Y, Zhuo Y.
europepmc +1 more source
Abstract Background Immune checkpoint inhibitors can be coadministered as a fixed‐ratio combination (FRC) or administered as sequential infusions (ASI). Two randomized, open‐label trials compared nivolumab + ipilimumab as a FRC versus ASI in patients with melanoma or renal cell carcinoma.
Alexander M. Menzies+19 more
wiley +1 more source
The biology of chronic myeloid leukemia: an overview of the new insights and biomarkers. [PDF]
Sicuranza A, Cavalleri A, Bernardi S.
europepmc +1 more source
ABSTRACT Gastric myeloid sarcoma (MS) is a rare disease with numerous endoscopic manifestations and is typically diagnosed on the basis of immunohistochemistry. However, the epidemiology, treatment, and prognosis of gastric MS remain controversial. The goal of this study is to preliminarily analyze these controversial aspects of gastric MS.
Cong Ding+7 more
wiley +1 more source
Divergent gene expression of <i>PTGS1</i> and <i>PTGS2</i> along the disease course of chronic myeloid leukaemia. [PDF]
Wosniaki DK+7 more
europepmc +1 more source
Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML
I. Sadovnik+20 more
semanticscholar +1 more source
Unveiling the Burden of Leukemia in Eritrea (2010-2020): Chronic Leukemia Stability, Rising ALL Incidence, and the Enigma of CML in a Low-Resource Setting. [PDF]
Abraha DM+10 more
europepmc +1 more source